Evox Therapeutics Limited products

Evox’s proprietary protein engineering technology enables loading of protein therapeutics and tissue targeting moieties onto the surfaces of exosomes, which allows targeting and display of therapeutic proteins to an organ of interest.

Nucleic acid-based therapeutics constitute a core therapeutic modality for Evox’s development programs, and we have sophisticated capabilities for the loading of various nucleic acids (primarily RNAs) into exosomes.

Targeted delivery of nanoparticles is an area that has been intensively researched. Targeted drug delivery has a role to play in the delivery of many if not all drugs, but targeted delivery systems are critical for the delivery of nucleic acid-based agents such as siRNA and CRISPR-Cas technology.